| Literature DB >> 20926681 |
Sanjay Katiyar1, Mathew C Casimiro, Luis Dettin, Xiaoming Ju, Erwin F Wagner, Hirokazu Tanaka, Richard G Pestell.
Abstract
c-jun, which is overexpressed in a number of human cancers encodes a critical component of the AP-1 complex. c-jun has been shown to either induce or inhibit cellular apoptosis. Germ line deletion of both c-jun alleles is embryonically lethal. To determine the role of the endogenous c-jun gene in apoptosis, we performed mammary epithelial cell-targeted somatic deletion using floxed c-jun (c-jun(f/f)) conditional knockout mice. Laser capture microdissection demonstrated endogenous c-jun inhibits expression of apoptosis inducing genes and reactive oxygen species (ROS)-reducing genes (MnSOD, catalase). ROS have been implicated in apoptosis and undergo enzymatic elimination via MnSOD and CuZnSOD with further detoxification via catalase. c-jun-mediated survival was in part dependent on ROS production. c-jun-mediated repression of MnSOD and catalase occurred via mitochondrial complex I and NOX I. Collectively, these studies define a pivotal role of endogenous c-jun in promoting cell survival via maintaining mitochondrial integrity and expression of the key regulators of ROS production.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20926681 PMCID: PMC2993753 DOI: 10.1091/mbc.E10-08-0705
Source DB: PubMed Journal: Mol Biol Cell ISSN: 1059-1524 Impact factor: 4.138
List of oligonucleotide primers used in PCR, RT-PCR, real-time qRT-PCR analysis, and chromatin immunoprecipitation assays
| Gene | Orientation | Sequence 5′→3′ |
|---|---|---|
| Forward | CTC ATA CCA GTT CGC ACA GGC GGC | |
| Reverse | CCG CTA GCA CTC ACG TTG GTA GGC | |
| Reverse | CAG GGC GTT GTG TCA CTG AGC T | |
| RPL-19 (DNA PCR) | Forward | AAT GCT CGG ATG CCT GAG AA |
| Reverse | CTC CAT GAG GAT GCG CTT GT | |
| Cre recombinase | Forward | TGC TCT GTC CGT TTG CCG |
| Reverse | ATC GTG TCC AGA CCA GGC | |
| RPL-19 (for RT-PCR) | Forward | CTG AAG GTC AAA GGG AAT GTG |
| Reverse | GGA CAG AGT CTT GAT GAT CTC | |
| Forward | AGA GCG GTG CCT ACG GCT ACA GTA A | |
| Reverse | CGA CGT GAG AAG GTC CGA GTT CTT G | |
| MnSOD | Forward | GCA CAT TAA CGC GCA GAT CA |
| Reverse | AGC CTC CAG CAA CTC TCC TT | |
| CuZnSOD | Forward | AAG GCC GTG TGC GTG CTG AA |
| Reverse | CAG GTC TCC AAC ATG CCT CT | |
| GPX | Forward | CCT CAA GTA CGT CCG ACC TG |
| Reverse | CAA TGT CGT TGC GGC ACA CC | |
| Catalase | Forward | GCA GAT ACC TGT GAA CTG TC |
| Reverse | GTA GAA TGT CCG CAC CTG AG | |
| Rac 1 | Forward | CTG CCT GCT CAT CAG TTA CACG |
| Reverse | GGA CAG AGA ACC GCT CGG ATA | |
| Rac 2 | Forward | CAG GTC AGG AGG ACT ATG ACC G |
| Reverse | GAT TGC CTC ATC GAA GAC GGT | |
| p40phox | Forward | CAA AGT CTA CAT GGG CGC AAA |
| Reverse | TGT CTT CAT AGA AGT AGC ATC GTA GCC | |
| p67phox | Forward | CTA TCT GGG CAA GGC TAC GGT T |
| Reverse | CAC AAA GCC AAA CAA TAC GCG | |
| gp91phox | Forward | AGT CGG GAT TTC TGA CCG GTA T |
| Reverse | TCC AGT CTC CAA CAA TAC GGA TAT G | |
| 18S r-RNA | Forward | AGG AAT TCC CAG TAA GTG CG |
| Reverse | GCC TCA CTA AAC CAT CCA A | |
| AP-1 elements | Forward | AGA AGT GAG TGG ATG TGA TGC CCA |
| Reverse | AGT ACA TCG TTG ACT GCA CGA CCT | |
| Negative (4) | Forward | TTC ATT TGC TGT CTG TCA CCG GG |
| Reverse | TGC AGA TAG TCC CAG CAT TGG GTA | |
| Oligos used for creating AP-1 deletion in MnSOD promoter constructs | Forward | CAG GGC ATA AAT TAA GAA GGC CCC TG |
| Reverse | CAG GGG CCT TCT TAA TTT ATG CCC TG |
Figure 1.Endogenous c-jun represses gene expression pathways governing cellular apoptosis and ROS production in vivo. (A) Schematic representation of intercrosses between MMTV-Cre and c-jun transgenic mice performed to produce c-jun+/+ and c-jun−/− mice. The mammary glands from these mice were subjected to laser capture microdissection (LCM) to enrich and purify mammary epithelial cells for performing microarray-based gene expression analysis. ASSESS pathway analysis was performed on the differentially expressed genes. The blue gradient coloration in the heat map shows down-regulation of the indicated pathways, whereas red depicts up-regulation of those pathways. (B) Heat map of differentially expressed pro- and antiapoptotic gene transcripts up- or down-regulated upon treatment of floxed c-jun cells with Ad-Null or Ad-Cre. (C) Scatter plot for the gene expression profiling performed using low-density apoptosis qRT-PCR arrays indicating expression of pro- and antiapoptosis genes, with the direction of gene expression show by red (up-regulated) and green (down-regulated) genes.
Figure 2.Somatic excision of c-jun induces mitochondrial and NOX1-dependent ROS production. (AI) Schematic diagram of the genomic wild-type (c-jun), floxed (c-jun), and deleted c-jun (c-junPΔ) locus with loxP sites (◀) and PCR primer binding sites (→). Adenovirus treatments to floxed c-jun cells, and resulting cellular genotypes. (II) Confocal microscopic images of Ad-Cre–treated c-jun fibroblasts showing expression of Cre-recombinase and c-jun. DAPI-stained nuclei. Note that the cells expressing Cre have lost c-jun expression. (III) RT-PCR showing expression of cre-recombinase, c-jun, and rpl-19 (housekeeping gene control) mRNA transcripts in RNA from no virus NS Ad-Null– and Ad-Cre–treated c-jun fibroblasts. PCR genotyping of DNA from no virus and Ad-Null– and Ad-Cre–treated c-jun cells showing floxed and excised c-jun alleles. (B) FACS-based quantification of DCFDA-stained ROS production in Ad-Null– and Ad-Cre–treated floxed c-jun cells (data are mean ± SEM). (C) High-resolution confocal microscopic images of the DCFDA staining of intracellular ROS in Ad-Cre–treated floxed c-jun cells. Mitotracker mitochondrial stain was used for visualization of mitochondria (data are mean ± SEM). (D) DCFDA staining of Ad-Null– or Ad-Cre–treated fibroblasts after addition of various ROS inhibitors.
Figure 3.c-jun determines mitochondrial membrane potential and apoptosis. (A) Annexin V staining for assessment of apoptotic cells after c-jun excision (data are mean ± SEM for n > 5). (B) Electron micrographs of the floxed c-jun cells with (No virus or Ad-Null) or without c-jun expression (Ad-Cre). (C) Mitochondrial membrane potential measurements using JC-1 mitochondrial probe after c-jun excision (data are mean ± SEM). (D) Quantitation of JC-1 staining and measurement of Dym, indicating a 3–5-fold increase in staining in c-jun−/− cells.
Figure 4.c-jun excision induces MnSOD expression via a ROS-dependent mechanism. (A) qRT-PCR–based assessment of expression of c-jun (I), MnSOD (II), CuZnSOD (III), catalase (IV), and GPX (V) transcripts at various time points after treatment of floxed c-jun cells with Ad-Null or Ad-cre to excise the c-jun gene. The real-time qRT-PCR expression data for various targets were normalized to amplification of 18S rRNA housekeeping gene control in every sample. (B) Expression of c-jun and MnSOD transcripts after treatment of Ad-Null– or Ad-Cre–treated floxed c-jun cells with the ROS inhibitor DPI. (C) Quantitation of H2O2 levels after c-jun excision and DPI treatment. (D) Catalase enzyme activities and (E) MnSOD enzyme activity in Ad-Null– or Ad-Cre–treated floxed c-jun cells in the presence of various ROS inhibitors (data are mean ± SEM).
Figure 5.Endogenous c-jun maintains survivin abundance. (A) mRNA and protein abundance for c-jun and survivin determined after acute excision of c-jun using Ad-Cre treatment of c-jun cells quantitated by RT-PCR (data are mean ± SEM for n > 5). (B) Western blot analysis of surviving abundance in wild-type versus c-jun−/− cells after treatment with ROS inhibitors for 24 h as indicated. (C) Western blot and DCFDA analysis of c-jun−/− cells transduced with retrovirus encoding c-jun. c-jun restores endogenous c-jun levels and reverses the increased production of ROS.